TITLE

Citalopram reduced depressive symptoms in coronary artery disease with depression

AUTHOR(S)
Lespérance, F.; Frasure-Smith, N.; Koszycki, D.
PUB. DATE
May 2007
SOURCE
ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p68
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study on the effectivity of citalopram and interpersonal psychotherapy in reducing depressive symptoms. Results revealed that citalopram improves the Hamilton Depression Rating Scale and Beck Depression Inventory II scores more than the placebo. It also indicated greater improvement in scores in Inventory of Depressive Severity and Interpersonal Relationships Inventory. It is concluded that citalopram reduces depressive symptoms more than the placebo.
ACCESSION #
25169113

 

Related Articles

  • Citalopram, but not interpersonal psychotherapy, improves major depression in people with coronary artery disease.  // Evidence Based Mental Health;Aug2007, Vol. 10 Issue 3, p80 

    The article presents a study which evaluates the effectiveness of citalopram or interpersonal psychotherapy and placebo or clinical management in managing major depression in people with coronary artery disease in Canada. Researchers conducted a randomized controlled trials in 284 outpatients...

  • Commentary. Parashar, Susmito; Rumsfeld, John S. // Evidence Based Mental Health;Aug2007, Vol. 10 Issue 3, p80 

    The article comments on the study which evaluates the effectiveness of citalopram or interpersonal psychotherapy and placebo or clinical management in managing major depression in patients with coronary artery disease. The author states that the data from the clinical trials are limited and does...

  • Citalopram reduced depressive symptoms in coronary artery disease with depression: COMMENTARY. Linden, Wolfgang // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p68 

    The author comments on a study on the effectivity of citalopram and interpersonal psychotherapy in reducing depressive symptoms. He claimed that the study clarifies the existence of effective treatment options for depressed cardiac patients. It is asserted that there is no convincing evidence in...

  • Citalopram Benefits Individuals with Coronary Artery Disease and Depression.  // Journal of Psychosocial Nursing & Mental Health Services;Apr2007, Vol. 45 Issue 4, p12 

    The article reports on the results of a study concerning the efficacy of the drug citalopram (Celexa®) in treating patients with depression. The study carried out to 284 patients with coronary artery disease (CAD) and depression showed that the drug can remedy the symptoms of depression. It...

  • Citalopram Useful for Depression in CDA Patients. Elliott, William T. // Clinical Oncology Alert;Mar2007 Pharmacology Watch, p1 

    The article discusses research being done on the use of citalopram to treat depression in patients diagnosed with coronary artery disease (CAD) in Canada. It references a study published in the 2007 issue of the "Journal of the American Medical Association." The study compared the effectiveness...

  • Citalopram Useful for Depression in CDA Patients. Elliott, William T. // Clinical Cardiology Alert;Mar2007 Pharmacology Watch, p1 

    The article discusses research being done on the use of citalopram to treat depression in patients diagnosed with coronary artery disease (CAD) in Canada. It references a study published in the 2007 issue of the "Journal of the American Medical Association." The study compared the effectiveness...

  • Atorvastatin reduced stroke and CV events after recent stroke or TIA in patients with no known coronary heart disease. Cheng, Eric // ACP Journal Club;Jan/Feb2007, Vol. 146 Issue 1, p7 

    The article cites a study regarding the effectiveness of atorvastatin in reducing stroke or transient ischemic attack (TIA) in patients not suffering from a coronary heart disease. The low-density lipoprotein cholesterol level was modified in patients with ischemic stroke. It was concluded that...

  • A Single Intravenous Dose of Ivabradine, a Novel I[sub f] Inhibitor, Lowers Heart Rate but Does Not Depress Left Ventricular Function in Patients with Left Ventricular Dysfunction. Lauck, Gerhard; Reuter, Marcus; Omran, Hegder; Jung, Werner; Manz, Matthias // Cardiology;2003, Vol. 100 Issue 3, p149 

    This randomized, single-blind, placebo-controlled study investigated the effect of ivabradine, a novel heart rate-lowering agent, on echocardiographic indices of left ventricular (LV) systolic function in patients with regional (coronary artery disease) or global (cardiomyopathy) LV dysfunction....

  • Effects of Selective Serotonin Reuptake Inhibitor Therapy on Endothelial Function and Inflammatory Markers in Patients With Coronary Heart Disease. Pizzi, C.; Mancini, S.; Angeloni, L.; Fontana, F.; Manzoli, L.; Costa, G. M. // Clinical Pharmacology & Therapeutics;Nov2009, Vol. 86 Issue 5, p527 

    We investigated the effect of sertraline on inflammation and endothelial function in patients with coronary heart disease (CHD) and symptoms of depression. One hundred patients with CHD and depression were randomized in a double-blind fashion to receive sertraline or a placebo. We measured...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics